[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351099-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351099-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteomic-atlas-of-human-peritoneal-tissue","Proteomic atlas of human peritoneal tissue","","Proteomic atlas of human peritoneal tissue is presented to address the limited understanding of the peritoneal tumor microenvironment. Peritoneal carcinomatosis is driven by metastatic involvement of parietal and visceral peritoneum, yet molecular assessment of this “soil” remains underdeveloped. Using liquid chromatography-tandem mass spectrometry with fresh frozen and FFPE benign samples on an ultra-high-resolution timsTOF system, the study catalogs baseline protein composition. ECM proteins show high abundance, and key signaling, metabolic, suppressor, and oncoproteins are quantified as reference data for future pathological comparisons.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteomic-atlas-of-human-peritoneal-tissue/351099/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteomic-atlas-of-human-peritoneal-tissue/351099.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about peritoneal carcinomatosis?","Question",{"text":63,"@type":64},"The study targets the gap that molecular methods for assessing the peritoneal tumor microenvironment are not well developed, limiting insight into how the peritoneal lining supports metastatic growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the proteomic samples prepared and analyzed?",{"text":68,"@type":64},"The work analyzed protein composition using liquid chromatography-tandem mass spectrometry on both fresh frozen and formalin-fixed paraffin-embedded benign tissue, measured with an ultra-high-resolution timsTOF mass spectrometer.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the proteomic atlas provide for future studies?",{"text":72,"@type":64},"It establishes a baseline catalog of the proteomic composition of the peritoneal lining, intended as a comparison dataset for future research on alterations in pathological states such as peritoneal carcinomatosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351099,1790493967,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nProteomic atlas of human peritoneal tissue  \nQiangmin Zhang1,2,3, Christopher Sherry2, Xi Peng1,2,3, Yunxiang Fu1,2,3, Nujsaubnusi Vue2,4, Rosie Blodgett2, Hyun Young Park1,2, Erin E. Grayhack1,2, Neda Dadgar2, Xue Li1,2,3, Ali H. Zaidi1,2, Vera Donnenberg5, David L. Bartlett1,2, Albert Donnenberg1,2,  \nKunhong Xiao1,2,3􀀍 & Patrick L. Wagner1,2􀀍  \nPeritoneal carcinomatosis occurs when the parietal and visceral peritoneum are involved with multifocal metastatic tumors, most commonly arising from abdominopelvic organ sites. The prevailing model of peritoneal carcinomatosis sees the peritoneal lining as the ‘soil’ onto which metastatic cancer cells attach and grow. Molecular methods to assess the functional status of this microenvironment have not been well developed. To address this gap, we analyzed the protein composition of peritoneal tissue using liquid chromatography-tandem mass spectrometry on both fresh frozen and formalinfixed, paraffin-embedded benign tissue (FFPE) samples, employing an ultra-high-resolution timsTOF mass spectrometer. The protein yield in peritoneal tissue was lower than that observed from similar studies of other visceral organ tissues. Extracellular matrix (ECM) proteins were present in high abundance and may be contributory to cancer cell attachment and invasion in peritoneal carcinomatosis. We further quantified key signal transduction and metabolic proteins known to contribute to cancer progression, along with defined tumor suppressors and oncoproteins. Our findings represent a baseline catalog of the proteomic composition of the peritoneal lining, as a comparison dataset for future studies focused on alterations in pathologic states such as peritoneal carcinomatosis.  \nKeywords Peritoneal tissue, Peritoneal carcinomatosis, LC-MS/MS, Proteomics  \nPeritoneal carcinomatosis (PC) is a devastating late manifestation of cancer, in which the peritoneal cavity and its organ contents are infiltrated by metastatic tumors. Although PC can arise from nearly any primary tumor type, the most common sites of primary tumor origin are the digestive and gynecologic organs. However, PC can originate from non-abdominal primary tumors, as well as from the peritoneal lining itself, which is the case in peritoneal mesothelioma or primary peritoneal carcinoma1. PC is difficult to manage, due to limitations on diagnostic imaging of the peritoneal cavity2,3, morbidity of peritoneal surgery4, and limited efficacy of chemotherapy5,6. Unfortunately, most patients experience progression to bowel obstruction, malnutrition, cachexia and death despite aggressive therapy regimens.  \nAlthough the overall prognosis of PC is poor, advances have been made in utilizing cytoreductive surgery alongside systemic and regional chemotherapy to provide meaningful benefit to selected patients6–8. Depending on the primary tumor type and underlying tumor biology, some subgroups of patients can expect durable control of PC and long-term survival outcomes that exceed historical results with palliative chemotherapy alone9. Importantly, as the number of molecularly targeted and immunotherapeutic options expands, a thorough understanding of the peritoneal tumor microenvironment (TME) will be vital if patients with PC are to benefit from these advances10–12.  \nNumerous technical approaches developed to investigate the peritoneal TME and the potential for targeted therapies have attained varying degrees of success. Biochemical and cytologic analyses are routinely utilized for diagnostic purposes in clinical practice but have limited specificity and sensitivity for discerning the presence of cancer and provide little insight into molecular characteristics of peritoneal fluid or cells. Molecular techniques have been employed to augment biomarker quantification, for example the multiplex bead-based Luminex assay to accurately measure cytokine levels13 and flow cytometry has bee","cbCaigKnh7KIEl9P","https://ap.wps.com/l/cbCaigKnh7KIEl9P","pdf",4188084,15,"English","# Introduction\n## Clinical background of peritoneal carcinomatosis\n## Need for molecular characterization\n# Proteomic approach\n## Sample collection and study objective\n## LC-MS/MS workflow and instrumentation\n# Baseline proteomic atlas\n## Protein yield and extracellular matrix findings\n## Quantification of signaling, metabolic, suppressor, and oncoproteins\n# Value for future research","[{\"question\":\"What problem does the study address about peritoneal carcinomatosis?\",\"answer\":\"The study targets the gap that molecular methods for assessing the peritoneal tumor microenvironment are not well developed, limiting insight into how the peritoneal lining supports metastatic growth.\"},{\"question\":\"How were the proteomic samples prepared and analyzed?\",\"answer\":\"The work analyzed protein composition using liquid chromatography-tandem mass spectrometry on both fresh frozen and formalin-fixed paraffin-embedded benign tissue, measured with an ultra-high-resolution timsTOF mass spectrometer.\"},{\"question\":\"What does the proteomic atlas provide for future studies?\",\"answer\":\"It establishes a baseline catalog of the proteomic composition of the peritoneal lining, intended as a comparison dataset for future research on alterations in pathological states such as peritoneal carcinomatosis.\"}]","Proteomic atlas of human peritoneal tissue | PDF",1790092626,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/807f13070c3b4deaa4db83e021b43f71.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0b7ad518b2612f9ea075b8ad8446454.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bd32bb3c1d64e21aca04bb95913fc8d.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97a36f27670e39e73b96a5ac2720c11d.webp",980,1287]